Skip to main content
SpringerLink
Log in

Comparative analysis of current US and EC biosafety regulations and their impact on the industry

  • Regulatory Issues
  • Published:
Journal of Industrial Microbiology

Summary

On July 18, 1991, the US National Institutes of Health added a section entitled ‘Good Large-Scale Practice’ (GLSP) to Appendix K of theGuidelines for Research Involving Recombinant DNA Molecules. Highlights of this section include the requirement for: (i) a health and safety program; (ii) well-trained personnel; (iii) facilities, clothing and practices appropriate to the risk of exposure; (iv) discharges to air, water and soil that must be done in accordance with environmental regulations; (v) aerosol generation that must be kept to a minimum so that employee health is not adversely affected; and (vi) a spill control plan. This complements the blueprint for regulation of biotechnology in the US (Coordinated Framework for Regulation of Biotechnology), in which the jurisdiction of each federal agency is established. Activities in Europe at this time included the adoption of three directives by the European Economic Community: ‘on the protection of workers from risk related to exposure to biological agents at work’, “on the contained use of genetically modified organisms”, and “on the deliberate release of genetically modified organisms”. The relationship of these new guidelines and regulations to existing practices and their potential impact on future activities are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ballard, J. 1992. Safety in the New Europe. Occupational Hazards. March, 1992: 65–67.

    Google Scholar 

  2. Brown, K. 1992. Regulatory Environment Rapidly Evolves in European Economic Community. Genetic Engineering News. April, 1992: 9–10.

    Google Scholar 

  3. Commission of the European Communities. 1991. Commission Decision of 29 July 1991 concerning the guidelines for classification referred to in Article 4 of Directive 90/219/EEC. 91/448/EEC. Official Journal of the European Communities. No. L 239: 23–26.

    Google Scholar 

  4. Commission of the European Communities. 1991. Commission Directive of 1 March 1991 adapting to technical progress for the twelfth time Council Directive 67/548/EEC of the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. 91/325/EEC. Official Journal of the European Communities. No. L 180: 1–78.

    Google Scholar 

  5. Council of the European Communities. 1989. Council Directive of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work. 89/391/EEC. Official Journal of the European Communities. No. L 183: 1.

    Google Scholar 

  6. Council of the European Communities. 1990. Council Directive of 23 April 1990 on the contained use of genetically modified micro-organisms. 90/219/EEC. Official Journal of the European Communities. No. L 117: 1–14.

    Google Scholar 

  7. Council of the European Communities. 1990. Council Directive of 23 April 1990 on the deliberate release into the environment of genetically modified organisms. 90/220/EEC. Official Journal of the European Communities. No. L 117: 15–27.

    Google Scholar 

  8. Council of the European Communities. 1990. Council Directive of 26 November 1990 on the protection of workers from risks related to exposure to biological agents at work. 90/679/EEC. Official Journal of the European Communities. No. L 374: 1–12.

    Google Scholar 

  9. Council of the European Communities. 1991. Draft proposal for a Council Directive amending Directive 90/679/EEC on the protection of workers from risks related to exposure to biological agents at work. Doc. No. 4903 EN.

  10. FCCSET Committee on Life Sciences and Health. 1992. Biotechnology for the 21st Century. Superintendent of Documents, ISBN 0-16-036101-X, Washington, DC.

  11. Frommer, W., et al. 1989. Safe Biotechnology. III. Safety Precautions. Appl. Microbiol. Biotechnol. 30: 541–552.

    Google Scholar 

  12. Mackay, D. EC 1992. and the Construction Products Directive. ASTM Standardization News. February, 1992: 48–52.

  13. Organization for Economic Cooperation and Development. 1986. Recombinant DNA Safety Considerations, Safety Considerations for industrial, agricultural and environmental applications of organisms derived by recombinant DNA techniques.

  14. Parliament of the European Communities. 1987. Treaty Establishing a Single Council and a Single Commission of the European Communities. Official Journal of the European Communities. No. L 152: 2.

    Google Scholar 

  15. United States National Insitutes of Health. 1976. Guidelines for Research Involving Recombinant DNA Molecules. In: Federal Register, Vol. 41, No. 131.

  16. United States National Institutes of Health. 1980. Physical Containment for Large Scale Uses of Organisms Containing Recombinant DNA Molecules. In: Federal Register, Vol. 45: 24968.

  17. United States National Institutes of Health. 1988. Guidelines for Research Involving Recombinant DNA Molecules. In: Federal Register, Vol. 53: 43411.

  18. United States National Institutes of Health. 1991. Guidelines for Research Involving Recombinant DNA Molecules. In: Federal Register, Vol. 56: 33178.

  19. United States Occupational Safety and Health Administration. 1991. Occupational Exposure to Bloodborne Pathogens. Title 29. Code of Federal Regulations, Part 1910.1030.

  20. United States Office of Science and Technology Policy. 1986. Coordinated Framework for Regulation of Biotechnology. In: Federal Register, Vol. 51: 23304.

  21. United States Office of Science and Technology Policy. 1986. Coordinated Framework for Regulation of Biotechnology. In: Federal Register, Vol. 51: 23308.

  22. United States Office of Science and Technology Policy. 1992. Exercise of Federal Oversight Within Scope of Statutory Authority: Planned Introductions of Biotechnology Products into the Environment. In: Federal Register, Vol. 57: 6753.

  23. Vogel, C. 1992. EC '92: Here Comes a New Set of Rules. Safety Health 145: 32–36.

    Google Scholar 

  24. Watson, J.D. and J. Tooze. 1981. The DNA Story: A Documentary History of Gene Cloning. W.H. Freeman and Company, San Francisco.

    Google Scholar 

Download references

Author information

Author notes

  1. Diane O. Fleming

    Present address: , 15611 Plumwood Court, 20716, Bowie, MD, USA

Authors and Affiliations

  1. The R.W. Johnson Pharmaceutical Research Institute, Route 202, P.O. Box 300, Raritan, NJ, USA

    Joseph Van Houten & Diane O. Fleming

Authors
  1. Joseph Van Houten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diane O. Fleming
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Houten, J., Fleming, D.O. Comparative analysis of current US and EC biosafety regulations and their impact on the industry. Journal of Industrial Microbiology 11, 209–215 (1993). https://doi.org/10.1007/BF01569593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01569593

Keywords

Search

Navigation